Category: St. Jude Medical
St. Jude Medical implants the 1st U.S. patient with its Nanostim leadless pacemaker, which is implanted directly in the heart.
St. Jude Medical (NYSE:STJ) today touted the 1st U.S. implant of its Nanostim pacemaker, a leadless device implanted directly into the heart to help regulate abnormal heart rhythms.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
St. Jude Medical says it will merge its 2 main divisions and streamline its worldwide manufacturing operations, promoting Michael Rousseau to COO and announcing the retirement of cardiovascular and ablation president Frank Callaghan.
St. Jude Medical implants the 1st U.K. patient with its Nanostim pacemaker, the 1st heart rhythm moderating device of its kind implanted directly in the heart.
Corrected January 28, 2014, 11:45 a.m.
Five product liability lawsuits filed against St. Jude Medical over its recalled Riata defibrillator leads withstand a bid to dismiss claims that St. Jude failed to warn about problems with the leads.
St. Jude Medical's 4th-quarter and 2013 results exceed expectations on Wall Street, sending share prices up today in pre-market trading.
St. Jude Medical (NYSE:STJ) topped expectations on Wall Street with its 4th-quarter and 2013 results, prompting early-bird investors to send share prices up today in pre-market trading.
Covidien said it's pulling the plug on its OneShot renal denervation device, citing the slow development of the hypertension market.
Covidien (NYSE:COV) said it plans to wind down its OneShot renal denervation program, largely due to "slower than expected development of the renal denervation market," meaning the end for a U.S. clinical trial of the high blood pressure device.